PHARMACOKINETICS OF GLYCEROL ADMINISTERED ORALLY IN HEALTHY-VOLUNTEERS

被引:0
|
作者
SOMMER, S [1 ]
NAU, R [1 ]
WIELAND, E [1 ]
PRANGE, HW [1 ]
机构
[1] ABT KLIN CHEM,GOTTINGEN,GERMANY
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1993年 / 43-2卷 / 07期
关键词
BLOOD FLOW ENHANCERS; CAS-56-81-5; GLYCEROL; CLINICAL PHARMACOKINETICS; OSMOTHERAPEUTICS;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Of the three standard osmotherapeutics glycerol, mannitol and sorbitol, glycerol (CAS 56-81-5) alone can be applied orally. As only limited pharmacokinetic data after oral administration are available, studies were performed in 10 healthy subjects (2 female, 8 male, body weight 58-90 kg, age 23-47 years). After 12 h of fasting the subjects drank a single dose of 1.2 g/kg glycerol (Glycerol 85% DAB 9, flavoured with lemon juice). For the first 90 min venous blood was sampled every 15 min, for the following 65 h every 30 min. Glycerol serum concentrations were determined by an enzymatic procedure. Intestinal absorption was rapid Maximum glycerol serum levels ranging from 1285-2238 mg/l (median = 1770 mg/l) were observed 1-2 h after ingestion. On the assumption of full intestinal absorption total body clearance was 0.18-0.26 l/h . kg, and the apparent volume of distribution 0.18-0.34 l/kg. The terminal elimination half-life ranged from 0.61-1.18 h. The concentration-time curves were not adequately described by linear pharmacokinetic models. In all subjects glycerol serum concentrations were high enough to induce increases of serum osmolality of at least 10 mosmol/kg. No signs of haemolysis or haemodilution were observed.
引用
收藏
页码:744 / 747
页数:4
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF ORALLY-ADMINISTERED TIZANIDINE IN HEALTHY-VOLUNTEERS
    TSE, FLS
    JAFFE, JM
    BHUTA, S
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1987, 1 (06) : 479 - 488
  • [2] EFFECTS OF ORALLY-ADMINISTERED ACTIVATED-CHARCOAL ON CIPROFLOXACIN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS
    TORRE, D
    SAMPIETRO, C
    QUADRELLI, C
    BIANCHI, W
    MAGGIOLO, F
    [J]. CHEMIOTERAPIA, 1988, 7 (06): : 382 - 386
  • [3] BIOEQUIVALENCE AND METABOLISM OF NITRENDIPINE ADMINISTERED ORALLY TO HEALTHY-VOLUNTEERS
    KANN, J
    KROL, GJ
    RAEMSCH, KD
    BURKHOLDER, DE
    LEVITT, MJ
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 : S968 - S973
  • [4] The pharmacokinetics of orally administered fudosteine in healthy Chinese volunteers
    H Y Jiao
    Z J Zhang
    F G Xu
    Y Tian
    B B Zhang
    Y Chen
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2006, 31 (2) : 65 - 71
  • [5] The pharmacokinetics of orally administered fudosteine in healthy Chinese volunteers
    Jiao, H. Y.
    Zhang, Z. J.
    Xu, F. G.
    Tian, Y.
    Zhang, B. B.
    Chen, Y.
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2006, 31 (02) : 65 - 71
  • [6] PHARMACOKINETICS OF INTRAVENOUSLY AND SUBCUTANEOUSLY ADMINISTERED FRAGMIN IN HEALTHY-VOLUNTEERS
    LOCKNER, D
    BRATT, G
    TORNEBOHM, E
    ABERG, W
    [J]. HAEMOSTASIS, 1986, 16 : 8 - 10
  • [7] PHARMACOKINETICS OF R(+)-TERODILINE GIVEN INTRAVENOUSLY AND ORALLY TO HEALTHY-VOLUNTEERS
    HALLEN, B
    GABRIELSSON, J
    PALMER, L
    EKSTROM, B
    [J]. PHARMACOLOGY & TOXICOLOGY, 1993, 73 (03): : 153 - 158
  • [8] Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers
    Ashley, Elizabeth S. Dodds
    Varkey, Jay B.
    Krishna, Gopal
    Vickery, Donna
    Lei Ma
    Xin Yu
    Malavade, Darshana
    Goodwin, Megan
    Perfect, John R.
    Power, Eddie
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 2960 - 2964
  • [9] BIOAVAILABILITY AND PHARMACOKINETICS OF NIFEDIPINE ADMINISTERED BY DIFFERENT ROUTES IN HEALTHY-VOLUNTEERS
    PALMAAGUIRRE, JA
    ROSASALCAZAR, G
    RODRIGUEZ, JM
    LEONURREA, F
    MONTOYACABRERA, MA
    [J]. ARCHIVOS DE INVESTIGACION MEDICA, 1989, 20 (02): : 129 - 135
  • [10] PHARMACOKINETICS OF TENIDAP SODIUM ADMINISTERED WITH FOOD OR ANTACID IN HEALTHY-VOLUNTEERS
    COATES, PE
    MESURE, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 : S17 - S19